Cargando…

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma

Detalles Bibliográficos
Autores principales:	Evens, Andrew M., Brandt, Justin S., Peer, Cody J., Yin, Tyler, Schaar, Dale, Farooq, Faheem, Mozarsky, Brett, Figg, William D., Sharon, Elad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Clinical Pearls in Blood Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314600/ https://www.ncbi.nlm.nih.gov/pubmed/35285979 http://dx.doi.org/10.1002/ajh.26527

Ejemplares similares

Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma
por: Carbone, Antonino, et al.
Publicado: (2023)

Cloak and dagger ‐ secondary hemophygocytic lymphohistiocytosis caused by intravenous autoinfection
por: Pircher, Andreas, et al.
Publicado: (2019)

Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19)
por: Nur, Erfan, et al.
Publicado: (2020)

B‐cell lymphoblastic lymphoma with cutaneous involvement and a KMT2A gene rearrangement
por: Kemps, Paul G., et al.
Publicado: (2020)

Isolated congenital asplenia: An overlooked cause of thrombocytosis
por: Borsani, Oscar, et al.
Publicado: (2022)

Mast cell sarcoma: 2 Mayo Clinic cases
por: Singh, Amritpal, et al.
Publicado: (2022)

Pseudoreticulocytosis in a patient with myelodysplastic syndrome
por: De Rossi, Noemy, et al.
Publicado: (2021)

Peripheral CD5+ CD10+ B‐cell proliferation with atypical morphology attributable to human herpesvirus 6 infection following umbilical cord blood transplantation
por: Canali, Alban, et al.
Publicado: (2022)

An unexpected finding during microscopy for urinary hemosiderin
por: Joshi, Nehal, et al.
Publicado: (2022)

A case of chronic neutrophilic leukemia and multiple myeloma showing the benefits of lenalidomide and cyclophosphamide therapy in treating both conditions
por: McVinnie, Kathryn, et al.
Publicado: (2022)

Granular B lymphoblastic leukemia
por: Hazarika, Biswadip, et al.
Publicado: (2022)

G6PD deficiency in patients identified as female
por: Bain, Barbara J., et al.
Publicado: (2022)

Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma
por: Tarekegn, Kidist, et al.
Publicado: (2021)

Checkpoint Inhibitors and the Changing Face of the Relapsed/Refractory Classical Hodgkin Lymphoma Pathway
por: Zhang, Xiao-Yin, et al.
Publicado: (2022)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

Catch the wave: Metabolomic analyses in human pathogenic fungi
por: Brandt, Philipp, et al.
Publicado: (2020)

Evolutionary Paradigms from Ancient and Ongoing Conflicts between the Lentiviral Vif Protein and Mammalian APOBEC3 Enzymes
por: Harris, Reuben S., et al.
Publicado: (2016)

Pirtobrutinib: a new hope for patients with BTK inhibitor–refractory lymphoproliferative disorders
por: Thompson, Philip A., et al.
Publicado: (2023)

Bacteria make surgical strikes on host ubiquitin signaling
por: Franklin, Tyler G., et al.
Publicado: (2021)

An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy
por: Farooq, Faheem, et al.
Publicado: (2023)

Investigating Fungal Outbreaks in the 21st Century
por: Litvintseva, Anastasia P., et al.
Publicado: (2015)

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
por: Moulis, Guillaume, et al.
Publicado: (2022)

Dual Immunotherapy Adds Value in Relapsed/Refractory Hodgkin Lymphoma
por: Hallam, Simon
Publicado: (2018)

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
por: Plaks, Vicki, et al.
Publicado: (2021)

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
por: Chen, Runzhe, et al.
Publicado: (2015)

New agents in relapsed/refractory Hodgkin's lymphoma()
por: Biasoli, Irene, et al.
Publicado: (2017)

Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy
por: Randall, Michael P., et al.
Publicado: (2023)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
por: Voorhees, Timothy J, et al.
Publicado: (2020)

P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma.
por: Mangasarova, Ya.K., et al.
Publicado: (2022)

ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
por: Choi, Chul Won, et al.
Publicado: (2002)

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
por: Siddiqi, Tanya, et al.
Publicado: (2014)

Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
por: Fedele, Roberta, et al.
Publicado: (2015)

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
por: Salihoglu, A., et al.
Publicado: (2014)

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
por: Angelopoulou, Maria K., et al.
Publicado: (2017)

Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
por: Phillips, Tycel, et al.
Publicado: (2022)

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy
por: Falchi, Lorenzo, et al.
Publicado: (2016)

Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
por: Gusak, Artem, et al.
Publicado: (2021)

A systematic review and meta-analysis of immune checkpoint therapy in relapsed or refractory non-Hodgkin lymphoma; a friend or foe?
por: Davoodi-Moghaddam, Zeinab, et al.
Publicado: (2023)

Impact of Endofungal Bacteria on Infection Biology, Food Safety, and Drug Development
por: Lackner, Gerald, et al.
Publicado: (2011)

Retroviral RNA Dimerization and Packaging: The What, How, When, Where, and Why
por: Johnson, Silas F., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_c1fbqaavlat7tsmda5jnvd8g3l